Neurobiology of depression and anxiety in parkinson's disease

Parkinson's Disease

Volumn , Issue , 2011, Pages

  Kano, Osamu ^a,b   Ikeda, Ken ^a   Cridebring, Derek ^b   Takazawa, Takanori ^a   Yoshii, Yasuhiro ^a   Iwasaki, Yasuo ^a  

^a TOHO UNIVERSITY OMORI MEDICAL CENTER   (Japan)

^b HOUSTON METHODIST RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID; ATOMOXETINE; BROMOCRIPTINE; NORTRIPTYLINE; PAROXETINE; PERGOLIDE; PLACEBO; PRAMIPEXOLE; ROPINIROLE;

ANXIETY DISORDER; COMORBIDITY; DEPRESSION; DISEASE ASSOCIATION; DOPAMINERGIC SYSTEM; DRUG EFFECT; DRUG TOLERABILITY; FOLLOW UP; GAIT DISORDER; IN VIVO STUDY; MOTOR DYSFUNCTION; NEUROBIOLOGY; NORADRENERGIC SYSTEM; PARKINSON DISEASE; PHOBIA; PRIORITY JOURNAL; REVIEW; SELF REPORT; SEROTONINERGIC SYSTEM;

EID: 79959206608     PISSN: None     EISSN: 20420080     Source Type: Journal    
DOI: 10.4061/2011/143547     Document Type: Review

References (38)

1. Parkinson J., An essay on the shaking palsy. 1817 The Journal of Neuropsychiatry and Clinical Neurosciences 2002 14 2 223 236
2. Schrag A., Quality of life and depression in Parkinson's disease Journal of the Neurological Sciences 2006 248 1-2 151 157 (Pubitemid 44647306)
3. O'Sullivan S. S., Williams D. R., Gallagher D. A., Massey L. A., Silveira-Moriyama L., Lees A. J., Nonmotor symptoms as presenting complaints in Parkinson's disease: a clinicopathological study Movement Disorders 2008 23 1 101 106 (Pubitemid 351281225)
4. Ross G. W., Abbott R. D., Petrovitch H., Morens D. M., Grandinetti A., Tung K. H., Tanner C. M., Masaki K. H., Blanchette P. L., Curb J. D., Popper J. S., White L. R., Association of coffee and caffeine intake with the risk of Parkinson disease Journal of the American Medical Association 2000 283 20 2674 2679 (Pubitemid 30337329)
5. Shulman L. M., Taback R. L., Rabinstein A. A., Weiner W. J., Non-recognition of depression and other non-motor symptoms in Parkinson's disease Parkinsonism and Related Disorders 2002 8 3 193 197 (Pubitemid 33091403)
6. Martinez-Martin P., Damian J., Parkinson disease: depression and anxiety in Parkinson disease Nature Reviews Neurology 2010 6 5 243 245
7. Chaudhuri K. R., Healy D. G., Schapira A. H., Non-motor symptoms of Parkinson's disease: diagnosis and management Lancet Neurology 2006 5 3 235 245 (Pubitemid 43238347)
8. Chaudhuri K. R., Naidu Y., Early Parkinson's disease and non-motor issues Journal of Neurology 2008 255 supplement 5 33 38
9. Savica R., Rocca W. A., Ahlskog J. E., When does Parkinson disease start? Archives of Neurology 2010 67 7 798 801
10. Shiba M., Bower J. H., Maraganore D. M., McDonnell S. K., Peterson B. J., Ahlskog J. E., Schaid D. J., Rocca W. A., Anxiety disorders and depressive disorders preceding Parkinson's disease: a case-control study Movement Disorders 2000 15 4 669 677 (Pubitemid 30479619)
11. Weisskopf M. G., Chen H., Schwarzschild M. A., Kawachi I., Ascherio A., Prospective study of phobic anxiety and risk of Parkinson's disease Movement Disorders 2003 18 6 646 651 (Pubitemid 36790279)
12. Bower J. H., Grossardt B. R., Maraganore D. M., Ahlskog J. E., Colligan R. C., Geda Y. E., Therneau T. M., Rocca W. A., Anxious personality predicts an increased risk of Parkinson's disease Movement Disorders 2010 25 13 2105 2113
13. Schuurman A. G., Van den Akker M., Ensinck K. T., Metsemakers J. F.M., Knottnerus J. A., Leentjens A. F.G., Buntinx F., Increased risk of Parkinson's disease after depression: a retrospective cohort study Neurology 2002 58 10 1501 1504 (Pubitemid 34552956)
14. Alonso A., Rodrguez L. A., Logroscino G., Hernn M. A., Use of antidepressants and the risk of Parkinson's disease: a prospective study Journal of Neurology, Neurosurgery and Psychiatry 2009 80 6 671 674
15. Jacob E. L., Gatto N. M., Thompson A., Bordelon Y., Ritz B., Occurrence of depression and anxiety prior to Parkinson's disease Parkinsonism and Related Disorders 2010 16 9 576 581
16. Pontone G. M., Williams J. R., Anderson K. E., Chase G., Goldstein S. A., Grill S., Hirsch E. S., Lehmann S., Little J. T., Margolis R. L., Rabins P. V., Weiss H. D., Marsh L., Prevalence of anxiety disorders and anxiety subtypes in patients with Parkinson's disease Movement Disorders 2009 24 9 1333 1338
17. Aarsland D., Marsh L., Schrag A., Neuropsychiatric symptoms in Parkinson's disease Movement Disorders 2009 24 15 2175 2186
18. Kuopio A. M., Marttila R. J., Helenius H., Toivonen M., Rinne U. K., The quality of life in Parkinson's disease Movement Disorders 2000 15 2 216 223 (Pubitemid 30166726)
19. Cummings J. L., Masterman D. L., Depression in patients with Parkinson's disease International Journal of Geriatric Psychiatry 1999 14 9 711 718 (Pubitemid 29450282)
20. Beekman A. T., Copeland J. R., Prince M. J., Review of community prevalence of depression in later life British Journal of Psychiatry 1999 174 307 311 (Pubitemid 29179713)
21. Burn D. J., Beyond the iron mask: towards better recognition and treatment of depression associated with Parkinson's disease Movement Disorders 2002 17 3 445 454 (Pubitemid 36040955)
22. Remy P., Doder M., Lees A., Turjanski N., Brooks D., Depression in Parkinson's disease: loss of dopamine and noradrenaline innervation in the limbic system Brain 2005 128 6 1314 1322 (Pubitemid 40826185)
23. Menza M., Dobkin R. D., Marin H., Mark M. H., Gara M., Buyske S., Bienfait K., Dicke A., A controlled trial of antidepressants in patients with Parkinson disease and depression Neurology 2009 72 10 886 892
24. Weintraub D., Mavandadi S., Mamikonyan E., Siderowf A. D., Duda J. E., Hurtig H. I., Colcher A., Horn S. S., Nazem S., Ten Have T. R., Stern M. B., Atomoxetine for depression and other neuropsychiatric symptoms in Parkinson disease Neurology 2010 75 5 448 455
25. Rektorova I., Rektor I., Bares M., Pramipexole and pergolide in the treatment of depression in Parkinson's disease: a national multicentre prospective randomized study European Journal of Neurology 2003 10 4 399 406 (Pubitemid 41754760)
26. Kano O., Ikeda K., Kiyozuka T., Iwamoto K., Ito H., Kawase Y., Sato R., Fujioka T., Araki Y., Baba S., Iwasaki Y., Beneficial effect of pramipexole for motor function and depression in Parkinson's disease Neuropsychiatric Disease and Treatment 2008 4 4 707 710
27. Roy A., Pickar D., Linnoila M., Doran A. R., Ninan P., Paul S. M., Cerebrospinal fluid monoamine and monoamine metabolite concentrations in melancholia Psychiatry Research 1985 15 4 281 292 (Pubitemid 15015246)
28. Lambert G., Johansson M., Agren H., Friberg P., Reduced brain norepinephrine and dopamine release in treatment-refractory depressive illness: evidence in support of the catecholamine hypothesis of mood disorders Archives of General Psychiatry 2000 57 8 787 793 (Pubitemid 30650115)
29. Rektorova I., Balaz M., Svatova J., Zarubova K., Honig I., Dostal V., Sedlackova S., Nestrasil I., Mastik J., Bares M., Veliskova J., Dusek L., Effects of ropinirole on nonmotor symptoms of Parkinson disease: a prospective multicenter study Clinical Neuropharmacology 2008 31 5 261 266
30. Pahwa R., Stacy M. A., Factor S. A., Lyons K. E., Stocchi F., Hersh B. P., Elmer L. W., Truong D. D., Earl N. L., Ropinirole 24-hour prolonged release: randomized, controlled study in advanced Parkinson disease Neurology 2007 68 14 1108 1115 (Pubitemid 46559844)
31. Pearson K. C., Mental disorders from low-dose bromocriptine New England Journal of Medicine 1981 305 3 173 (Pubitemid 11073090)
32. Bxarone P., Poewe W., Albrecht S., Debieuvre C., Massey D., Rascol O., Tolosa E., Weintraub D., Pramipexole for the treatment of depressive symptoms in patients with Parkinson's disease: a randomised, double-blind, placebo-controlled trial The Lancet Neurology 2010 9 6 573 580
33. Barone P., Scarzella L., Marconi R., Antonini A., Morgante L., Bracco F., Zappia M., Musch B., Pellecchia M. T., Amboni M., Schiatti A., Carapelli S., Pezzoli G., Tesei S., Epifanio A., Gasparoli E., Arabia G., Papini M. G., Battaglia A., Pramipexole versus sertraline in the treatment of depression in Parkinson's disease: a national multicenter parallel-group randomized study Journal of Neurology 2006 253 5 601 607 (Pubitemid 43876990)
34. Vajda F. J., Solinas C., Current approaches to management of depression in Parkinson's disease Journal of Clinical Neuroscience 2005 12 7 739 743 (Pubitemid 41411876)
35. Dissanayaka N. N., Sellbach A., Matheson S., O'Sullivan J. D., Silburn P. A., Byrne G. J., Marsh R., Mellick G. D., Anxiety disorders in Parkinson's disease: prevalence and risk factors Movement Disorders 2010 25 7 838 845
36. Mathew S. J., Coplan J. D., Gorman J. M., Neurobiological mechanisms of social anxiety disorder American Journal of Psychiatry 2001 158 10 1558 1567 (Pubitemid 32923643)
37. Nutt D. J., Bell C. J., Malizia A. L., Brain mechanisms of social anxiety disorder Journal of Clinical Psychiatry 1998 59 supplement 17 4 11
38. Negre-Pages L., Grandjean H., Lapeyre-Mestre M., Anxious and depressive symptoms in Parkinson's disease: the French cross-sectionnal DoPAMiP study Movement Disorders 2010 25 2 157 166